UNC HEALTH Pharmacy and Therapeutics Series

The "UNC Health System Pharmacy and Therapeutics (P&T) Committee Series" offers healthcare professionals an in-depth exploration of key pharmacologic updates, formulary recommendations, and clinical management strategies that impact system-wide patient care. At the P&T meeting on March 17, participants will use principles of evidence-based medicine to evaluate formulary change recommendations, assess the impact of optimization initiatives, and develop strategies to optimize patient care and safety across the UNC Health Care System. This series is designed to enhance clinical decision-making, address medication safety concerns, and discuss the cost-effectiveness of therapeutic options, equipping attendees with actionable knowledge to optimize pharmacological practices across diverse healthcare settings.

Target Audience

This activity is designed for an audience of Physicians and Pharmacists.

Learning Objectives

  • Describe the differences in adverse event profiles for nafcillin and oxacillin
  • Evaluate efficacy, safety, operational, and cost considerations related to the formulary addition of buprenorphine ER for injection for opioid use disorder treatment.
  • Explain how results of the DREAMM-7 study impacted the re-entry of belantamab mafodotin to the US market.  
  • Identify clinical and operational implications of ongoing drug shortages. 

 

Commercial Support
There is no commercial support for this activity.

 

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
03/16/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
Tuesday, March 17, 2026 in Chapel Hill, NC
United States

 

 

 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and UNC Health. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.0 contact hours.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.